GlassScriptPhysician profile
George M Brinson
NPI 1861454399
$3,065.02
in general payments reported to CMS, 2019-2025
20 companies · $1,124 in 2025
The $1,124 reported for 2025 was more than what 82% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $93.54 · 2021: $153 · 2022: $316 · 2023: $459 · 2024: $630 · 2025: $1,124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,180 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,179.69 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $544.71 | 2023-2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Glaxosmithkline, LLC. | $529.01 | 2022-2025 | Nucala |
| Genzyme Corporation | $413.11 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $251.78 | 2019-2025 | Dupixent, Libtayo |
| Acclarent, INC | $207.60 | 2021-2022 | |
| Stryker Corporation | $191.83 | 2019-2025 | Xerogel Nasal/Epistaxis 2 Pack, Audion Et Dilation System |
| Oticon Medical, LLC | $170.67 | 2024-2025 | Ponto Bone Anchored Hearing System |
| Merck Sharp & Dohme LLC | $148.85 | 2025 | Keytruda, Keytruda Qlex |
| Advanced Bionics, LLC | $144.01 | 2019 | |
| Amgen INC. | $91.16 | 2025 | Tezspire |
| Med-El Corporation | $76.13 | 2022-2024 | Mi1250 Synchrony 2 Flexsoft |
| Aerin Medical INC. | $59.91 | 2025 | |
| Optinose US, INC. | $54.99 | 2019-2023 | |
| Phathom Pharmaceuticals, INC. | $41.39 | 2025 | Voquezna |
| Ars Pharmaceuticals Operations, INC. | $40.42 | 2025 | Neffy |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $26.39 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $22.69 | 2025 | |
| Resmed Corp | $21.54 | 2024 | |
| Novartis Pharmaceuticals Corporation | $14.66 | 2025 | |
| Axogen | $14.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Brinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.